Brief: China Biotech Services Announces MoU To Setup A Research & Development And Production Base

China Biotech Services Holdings

14/09/2021 23:12

Sept 15 (Reuters) - China Biotech Services Holdings Ltd
 8037.HK :
    * ANNOUNCES A MOU WITH ADMINISTRATIVE COMMISSION OF RUDONG
NEW AND
HI-TECH INDUSTRIAL DEVELOPMENT ZONE OF JIANGSU
    * AN ADMINISTRATIVE COMMISSION-LED INDUSTRIAL FUND PROPOSES
TO
INVEST RMB50 MILLION IN UNIT
    * INVESTMENT COMPRISING RMB30 MILLION OF DEBT INVESTMENT &
RMB20
MILLION OF EQUITY INVESTMENT
    * MOU FOR PROPOSED INVESTMENT IN A NEW UNIT OF CO ENGAGED IN
RESEARCH AND DEVELOPMENT OF INNOVATIVE IMMUNE CELL THERAPIES
    * PRE-MONEY VALUATION OF THIS ROUND OF INVESTMENT IS
TENTATIVELY
SET AT RMB1.2 BILLION, TO BE CONFIRMED BY INVESTORS
    * CHINA HIGHRUN CAPITAL ALSO PROPOSES TO INVEST RMB50
MILLION IN
SHANGHAI LONGYAO AS EQUITY INVESTMENT
    * APPLICATION HAS BEEN MADE FOR RESUMPTION OF TRADING IN
SHARES
FROM 9:00 A.M. ON WEDNESDAY, SEP 15

Source text https://www1.hkexnews.hk/listedco/listconews/gem/2021/0915/2021091500005.pdf
Further company coverage:  8037.HK 

 ((Reuters.Briefs@thomsonreuters.com;))